These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 18330322)

  • 1. Critical appraisal of currently used oxytocin regimen and prospects.
    Berhan Y; Dwivedi AD
    Ethiop Med J; 2007 Jul; 45(3):225-34. PubMed ID: 18330322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Currently used oxytocin regimen outcome measures at term & postterm. I: Outcome indicators in relation to parity & indication for induction.
    Berhan Y; Dwivedi AD
    Ethiop Med J; 2007 Jul; 45(3):235-42. PubMed ID: 18330323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Currently used oxytocin regimen outcome measures at term & postterm. II: Outcome indicators in relation to Bishop Score & other covariates.
    Berhan Y; Dwivedi AD
    Ethiop Med J; 2007 Jul; 45(3):243-50. PubMed ID: 18330324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxytocin augmentation of labor and perinatal outcome in nulliparas.
    Akoury HA; MacDonald FJ; Brodie G; Caddick R; Chaudhry NM; Frize M
    Obstet Gynecol; 1991 Aug; 78(2):227-30. PubMed ID: 2067766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High- versus low-dose oxytocin for labor stimulation.
    Satin AJ; Leveno KJ; Sherman ML; Brewster DS; Cunningham FG
    Obstet Gynecol; 1992 Jul; 80(1):111-6. PubMed ID: 1603479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High- versus low-dose oxytocin for augmentation or induction of labor.
    Patka JH; Lodolce AE; Johnston AK
    Ann Pharmacother; 2005 Jan; 39(1):95-101. PubMed ID: 15572602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized comparison of 15- and 40-minute dosing protocols for labor augmentation and induction.
    Lazor LZ; Philipson EH; Ingardia CJ; Kobetitsch ES; Curry SL
    Obstet Gynecol; 1993 Dec; 82(6):1009-12. PubMed ID: 8233251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving patient safety and uniformity of care by a standardized regimen for the use of oxytocin.
    Hayes EJ; Weinstein L
    Am J Obstet Gynecol; 2008 Jun; 198(6):622.e1-7. PubMed ID: 18355786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomised controlled trial of early versus delayed oxytocin augmentation to treat primary dysfunctional labour in nulliparous women.
    Hinshaw K; Simpson S; Cummings S; Hildreth A; Thornton J
    BJOG; 2008 Sep; 115(10):1289-95; discussion 1295-6. PubMed ID: 18715415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Labour induction with an intermediate-dose oxytocin regimen has advantages over a high-dose regimen.
    Manjula BG; Bagga R; Kalra J; Dutta S
    J Obstet Gynaecol; 2015 May; 35(4):362-7. PubMed ID: 25384080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early versus delayed oxytocin augmentation in nulliparous women with prolonged labour--a randomised controlled trial.
    Dencker A; Berg M; Bergqvist L; Ladfors L; Thorsén LS; Lilja H
    BJOG; 2009 Mar; 116(4):530-6. PubMed ID: 19250364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of a conservative checklist-based protocol for oxytocin administration: maternal and newborn outcomes.
    Clark S; Belfort M; Saade G; Hankins G; Miller D; Frye D; Meyers J
    Am J Obstet Gynecol; 2007 Nov; 197(5):480.e1-5. PubMed ID: 17980181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical doctors profile in Ethiopia: production, attrition and retention. In memory of 100-years Ethiopian modern medicine & the new Ethiopian millennium.
    Berhan Y
    Ethiop Med J; 2008 Jan; 46 Suppl 1():1-77. PubMed ID: 18709707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failed induction of labour.
    Arulkumaran S; Gibb DM; TambyRaja RL; Heng SH; Ratnam SS
    Aust N Z J Obstet Gynaecol; 1985 Aug; 25(3):190-3. PubMed ID: 3866556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Start of induction of labour with oxytocin in the morning or in the evening. A randomised controlled trial.
    Bakker JJ; De Vos R; Pel M; Wisman C; Van Lith JM; Mol BW; Van Der Post JA
    BJOG; 2009 Mar; 116(4):562-8. PubMed ID: 19250367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Titrated low-dose vaginal and/or oral misoprostol to induce labour for prelabour membrane rupture: a randomised trial.
    Bricker L; Peden H; Tomlinson AJ; Al-Hussaini TK; Idama T; Candelier C; Luckas M; Furniss H; Davies A; Kumar B; Roberts J; Alfirevic Z
    BJOG; 2008 Nov; 115(12):1503-11. PubMed ID: 18752586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy and safety of vaginal misoprostol versus dinoprostone vaginal insert in labor induction at term: a randomized trial.
    Ozkan S; Calişkan E; Doğer E; Yücesoy I; Ozeren S; Vural B
    Arch Gynecol Obstet; 2009 Jul; 280(1):19-24. PubMed ID: 19034471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re: Oxytocin induction of labour: a comparison of two protocols.
    Parashi S; Bonabi NB; Rashidi A
    Aust N Z J Obstet Gynaecol; 2005 Dec; 45(6):540. PubMed ID: 16401232
    [No Abstract]   [Full Text] [Related]  

  • 19. Oxytocin augmentation in grandmultiparous parturients: to give or not to give?
    Bentov Y; Sheiner E
    Arch Gynecol Obstet; 2009 Jun; 279(6):781-3. PubMed ID: 19277689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of labour: a comparison between controlled-release dinoprostone vaginal pessary (Cervidil) and dinoprostone intravaginal gel (Prostin E2).
    Kho EM; Sadler L; McCowan L
    Aust N Z J Obstet Gynaecol; 2008 Oct; 48(5):473-7. PubMed ID: 19032662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.